推荐应用
LILRA1, also known as CD85i and LIR-6, is an approximately 70 kDa variably glycosylated transmembrane protein that regulates immune cell activation. Mature human LILRA1 consists of a 445 amino acid (aa) extracellular domain (ECD) with 4 Ig-like domains, a 21 aa transmembrane segment, and a 7 aa cytoplasmic tail. The transmembrane segment contains a positively charged arginine which may mediate association with signaling molecules. Alternative splicing generates an isoform that lacks the third and fourth Ig-like domains. LILRA1 is expressed on monocytes and binds to the free heavy chain of the MHC class I molecule HLA-B27. It is activated in response to the BCG mycobacterial strain.
高纯度、高活性、低内毒素、高批间一致性
产品数据
-25 ~ -15℃保存，收到货之后有效期1年。 复溶后， 无菌条件下，-85 ~ -65℃保存，3个月有效期。
【应用方向】免疫检查点核心家族：B7-CD28超家族蛋白
423
2026-04-21
【应用方向】TIM-3：下一代肿瘤免疫检查点治疗的核心靶点
317
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
290
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
325
2026-04-21
【应用方向】LILRB家族：髓系细胞免疫检查点的研究前沿与产品解决方案
385
2026-04-21
【应用方向】LAG-3（CD223）：T细胞耗竭调控网络的核心节点
332
2026-04-21
【应用方向】B7-H3（CD276）：双重功能免疫检查点的分子特征与科研应用
502
2026-04-20
